Summary and Action Items

A new SARS-CoV-2 variant that contains a large number of mutations (Pango lineage B.1.1.529, WHO Variant of Concern “Omicron”) has been detected in Africa, Asia, Australasia, Europe and North America.
As of November 29, 2021, Omicron has not been identified in the United States, but it is likely that cases will be detected in the coming days and weeks.
Laboratories that submit specimens to CDPH’s Regional Innovative Public Health Laboratory (RIPHL) are usually encouraged to submit at least 15 routine surveillance specimens each week for genomic characterization. To enhance genomic surveillance, laboratories are temporarily requested to submit 30 routine surveillance specimens each week.
Laboratories performing genomic sequencing are encouraged to sequence virus isolates in a timely manner and upload to public databases.

Please see the attachment for more details.

Menu nawigacji

Pasek wyszukiwania